BiPAP for Cardiomyopathy With Central Sleep Apnea
1 other identifier
interventional
N/A
1 country
1
Brief Summary
We investigated whether treatment of central sleep apnea-hypopnea with bilevel positive airway pressure (BiPAP) in patients with idiopathic dilated cardiomyopathy (IDCM) would improve LV function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2000
CompletedFirst Submitted
Initial submission to the registry
January 26, 2006
CompletedFirst Posted
Study publicly available on registry
January 27, 2006
CompletedJanuary 30, 2006
June 1, 2000
January 26, 2006
January 27, 2006
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Idiopathic dilated cardiomyopathy
You may not qualify if:
- a history of alcohol abuse, diabetes mellitus, endocrine disorders, hypertension, obstructive sleep apnea syndrome, and chronic obstructive pulmonary disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nagoya University of Health Sciences
Nagoya, 461-8673, Japan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mitsuhiro Yokota, MD,PhD
Department of Cardiovascular Genome Science, Nagoya University School of Medicine, Nagoya, Aichi, Japan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 26, 2006
First Posted
January 27, 2006
Study Start
June 1, 2000
Last Updated
January 30, 2006
Record last verified: 2000-06